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Methods: This proof-of-concept randomized controlled trial tests an evidence-based multidomain
lifestyle intervention in 146 persons aged 40 to 64 years, in northern Utah. Data collectors were
blinded to participants’ randomization to treatment (n 5 104) or control (n 5 42). Intervention tar-
geted physical activity, food choices, social engagement, cognitive simulation, sleep quality, and
stress management, and uses a custom smartphone application, activity monitor, and educational ma-
terials. Secondary outcomes include biomarkers, body mass index, cognitive testing, and psycholog-
ical surveys.
Results: Midway through the study, achievements include a 98.7% retention rate, a 96% rate of
compliance with app data entry, and positive trends in behavioral change.
Discussion: Participants were empowered, learning that lifestyle might impact AD risk, exhibiting
positive behavioral changes thus far.
 2015 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
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iants may account for roughly 30% of variance in risk for AD
[3], implies that a substantial portion of risk may be the result
of modifiable “environmental factors” [4].
Physical activity has been linked to better cognitive func-
tion [5] and lower AD risk [6], potentially via neuroprotec-
tion through increased neurogenesis and the enhancement of
brain cytoarchitecture [7]. Additionally, healthy diet and
good nutrition are linked to lower dementia risk, including
dietary patterns rich in fruits, vegetables, whole grains,imer’s Association. This is an open access article under the CC BY-NC-ND
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development of AD via the modulation of biochemical pro-
cesses that influence AD neuropathology [9], and greater so-
cial engagement has been associated with lower rates of
incident dementia [10,11].
Midlife health has implications for later dementia as
obesity [12], hypertension [13], and serum cholesterol [14]
have been linked to higher dementia risk in late life. Because
of the multidimensional risk factors for AD and a strong
evidence of a long presymptomatic phase [15], multidomain
preventive interventions are critically needed in midlife (and
earlier) to maximize the effect on AD risk reduction [16].
Recent multidomain randomized controlled trials (RCTs).
Encouraging individuals to change multiple domains of their
lifestyle has inherent challenges [17]; however, a variety of
intervention modalities may be useful and successful. In a
recent study of 80 middle-aged persons, King et al. [18]
demonstrated that participants using three different smart-
phone apps focusing on (1) goal setting/monitoring, (2) so-
cial comparisons and supports, or (3) operant conditioning,
each showed increases in physical activity levels. Smith-
DiJulio and Anderson [19] implemented a multimodal life-
style cardiovascular risk intervention in 60 middle-aged
women in Australia, finding that subjects were generally
continuing healthy behaviors in a 5-year follow-up survey.
Anstey and colleagues are currently conducting a multido-
main health education RCT in Australia among 176
middle-aged persons, including three groups—online only,
online and face-to-face, and active control [20]. Similarly,
multidomain prevention trials are being conducted among
older adults at higher AD risk, emphasizing exercise and
nutritional advice [21] in combination with cognitive
training [22,23] or medical treatment of risk factors [24].
In summary, a number of RCTs designed to lower AD
risk via lifestyle behavioral change have commenced in
recent years; however, nearly all these studies focus on older
adults or on middle-aged persons at higher risk for AD.
Indeed, nonewere found that targeted the general population
of middle-aged individuals, in the United States or else-
where, and none have taken a holistic approach to encourage
positive lifestyle changes in as many domains as the study
reported herein.
Gray Matters is a multidomain pilot RCT designed to pro-
mote positive changes in lifestyle (exercise, nutrition, cogni-
tive stimulation, social engagement, stress management, and
sleep quality), specifically for the purpose of reducing AD
risk in healthy middle-aged adults (ClinicalTrials.gov Identi-
fier: NCT02290912). The study serves as a proof-of-concept
design; data from the project informs research and will also
inform future interventions. The transtheoretical model of
behavior change [25] provides a theoretical foundation for
the intervention, guiding the assessment of individuals’ moti-
vation and readiness to change, alongside the measurement
of behavioral and health outcome change. The goal for each
domain is to introduce evidence-based associations explain-
ing AD risk and encourage positive changes. This RCT iscurrently underway in Cache County, Utah, and we report
here the methods and baseline sample characteristics.1. Methods
1.1. Study design
This pilot study is an RCT; immediately after the pretest
data collection (to ensure examiners were blinded), subjects
were randomly assigned into treatment or control condition.
The treatment group was not given a strictly prescribed
regimen and consequently a wide range of engagement
levels was anticipated. Hence, two-thirds of the sample
was randomized to treatment and one-third to control, using
a uniform (0,1) random number generator within SPSS v. 21.
The intervention was delivered over a 6-month period (start-
ing April 2014) with posttest data collection planned at 6
months.
1.2. Participants
The study used a convenience sampling approach.
Recruitment efforts included a marketing flyer distributed
through USU listservs, local health fairs, and county health
department liaisons. Interested persons completed a prescre-
ening eligibility survey. To achieve 80% statistical power to
detect a medium effect size (Cohen’s d 5 0.50) when
comparing the difference between two independent means
at a 2:1 treatment:control ratio, 96 treatment and 48 control
(144 total) participants were needed (G*Power; http://www.
psycho.uni-duesseldorf.de/abteilungen/aap/gpower3/). The
2:1 ratio was chosen because it maximized the number of
individuals receiving treatment, while minimizing cost (bud-
gets were restricted because of the pilot-nature of the study).
Additionally, given that the intervention program allowed
participants to create their own custom behavior change
plan, the 2:1 ratio facilitated the option at study’s end to
examine change within each behavioral domain among the
subsample of participants who indicated that it was their
priority to focus change efforts on the given domain. We
enrolled the first 146 persons who met eligibility criteria.
After randomization, both spouses in 12 married couples
were assigned to the same group to avoid the intracouple
contamination of intervention content. The final assignments
included 104 participants in the treatment group and 42
participants in the control group, resulting in final statistical
power of 78%. A flowchart depicting recruitment, enroll-
ment, randomization, and follow-up throughout the study,
following the Consolidated Standards of Reporting Trials
guidelines, appears in Fig. 1.
Eligibility criteria included the following: (1) age be-
tween 40 and 64 years, (2) body mass index no higher
than 41, (3) possession of a smartphone or tablet (iOS or
Android), (4) fluency in the English language, (5) residence
in Cache County, and (6) not having any of the following
exclusionary medical conditions: pregnancy, dementia, un-
managed diabetes, or untreated major depression. Note
Fig. 1. Flow diagram of participant recruitment, enrollment, randomization, and follow-up in the Gray Matters Alzheimer’s Disease Prevention Study.
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cognitive impairment was not.
1.3. Intervention program
The intervention provides evidence-based information
linking lifestyle behaviors and cognitive decline or risk for
AD or other dementia. Six behavioral domains associated
with AD risk were targeted: physical activity, healthy food
choices, social engagement, cognitive stimulation, stress
management and sleep quality. Activity Monitor: Each
participant received a Nike FuelBand SE activity monitor,
tracking steps taken, calories burned and a proprietary
metric, “Nike Fuelpoints.” The monitors also provided a
visible reminder to engage in physical activity daily.
1.3.1. Educational components
After an initial “kickoff event” with a motivational speaker
and six informative booths, the intervention included the
following elements: A series of 39 “booster events” were
delivered over the 6-month intervention period. Booster ses-
sions were designed to emphasize the link between a behav-
ioral domain and AD risk and to give participants experiential
opportunities to try example behaviors, the overall behavioral
domain being promoted, rather than specific activities. Forexample, individual nutrients or food items were not pro-
moted, rather, a healthy overall dietary pattern rich in fruits,
vegetables, whole grains, fish and lean meats, akin to the Di-
etary Approaches to StopHypertension diet [26], theMediter-
ranean diet [27], and the United States Department of
Agriculture dietary recommendations [28]. Participants
were advised to check with their physicians before substan-
tially increasing their physical activity, and were given Cen-
ters for Disease Control and Prevention recommendations
of 150 minutes/week of moderate and 75 minutes/week of
vigorous physical activity as a general guideline.
1.3.2. Social engagement workbook
A weekly workbook was provided, featuring activities
based on empirical findings related to quality social support,
perceived support, conflict resolution, and emotional/instru-
mental support. The workbook was designed to help partic-
ipants set goals, follow through, and reflect on building or
maintaining quality social support and relationships.
1.3.3. Smartphone application
Participants were given an app created for this study and
designed to work on Apple iOS and Android OS smart-
phones and tablets. This technology included three primary
functions (Fig. 2). Information: Tapping a “daily fact”
Fig. 2. Key functions of the Gray Matters smartphone app (for smartphone or tablet; iOS or Android). (A) The factoid and suggestion screen (“Tips”). (B)
Behavioral data entry screen with 12 questions (“Your Log”). (C) Daily feedback for each domain with star ratings (“Performance”). (D) Weekly summary
presented in a bar chart across all domains (“More”).
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and concrete suggestions for adoption. (e.g. “Lack of phys-
ical activity is a risk factor for AD. Try taking a walk during
your lunch break.”) Accountability: Subjects were asked
daily to respond to a set of 10 behavioral questions, taking
2 minutes/day total to complete. The 10 questions enquired
about physical activity level (moderate and vigorous), con-
sumption of fruits/vegetables, whole grains, legumes/nuts,
cognitively stimulating activities, novel information pro-
cessing activities, sleep improvement efforts, social engage-
ment, and stress reduction efforts. Data entry took the form
of a user-friendly horizontal “slider.” Feedback: The
app provided a progress report with two graphical displays
(1–5 stars daily and histogram weekly).
1.3.4. Personal coach
A team of 28 student interns volunteered to be “personal
coaches” and were trained in motivational interviewing
and the transtheoretical model. Coaches provided a weekly
email or text message exchange with their “clients” to
provide emotional support and encouragement for life-
style change goals, keeping a log monitored by facultyresearchers, who provided assistance in resolving any ques-
tions or issues.
1.3.5. Study website
A website was created and shared with participants,
providing intervention content in the six domains. The web-
site provided links to other resources, study technology sup-
ports, and an email portal for submitting questions to the
research team.1.4. Procedures
The Institutional Review Board at Utah State University
approved this research, and written informed consent was
collected from all participants. At each participant’s clinic
visit, height, weight, pulse, and blood pressure were
measured, and a urine sample and venous blood sample
were collected. A clinic nurse (consulting with clinic
physician as needed) reviewed the detailed medical history,
identified potential exclusionary conditions, and reviewed
all current treatment regimens (only two were excluded
because of health and safety concerns). Laboratory reports
were emailed to each participant. In approximately 10
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sults were notified promptly by telephone and were advised
to see their primary care provider to discuss further evalu-
ation and treatment, but were allowed to enroll in the study.
Participants completed a 1-hour battery of paper-pencil
and computerized cognitive tests at a separate clinic visit,
administered by trained psychometrists (extensively
trained and field certified by the study neuropsychologist
J. Tschanz). Once laboratory work and cognitive testing
were completed, participants then completed online sur-
veys. Once pretest data collection was complete and
random assignments were made, participants received an
email announcing their experimental group assignment.
During the course of the 6-month intervention period
(April–October, 2014), control subjects received no con-
tact other than data collection whereas treatment subjects
received all intervention components as described previ-
ously. Treatment subjects were encouraged to make
healthy behavioral changes, whereas control subjects
were encouraged to “go on about their lives as if they
were not in the study” over the intervention period. To
better approximate a real-world implementation of this
intervention, treatment group participants were not
required to follow a strict behavioral regimen over the
6-month intervention period, rather, they were permitted
to engage in whichever components of the intervention
they desired “cafeteria style.”
Participants from treatment and control groups are slated
to complete a posttest data collection protocol October
through December 2014, using the same procedures as in
the pretest data collection—laboratory work, cognitive
testing, and surveys. Control participants were aware via
informed consent that the study involved lifestyle behaviors
related to risk for AD, but as stated previously, did not have
contact with the interventionists over the 6 months of inter-
vention. They are slated to receive the intervention materials
immediately on completing the posttest data collection
protocol.1.5. Measurement
Primary outcome measures were behavior in six targeted
domains. Secondary outcome measures included anthropo-
metric measures, blood-based biomarkers, metacognition,
motivation, readiness-for-change, sleep quality, social
engagement, depression, couple satisfaction (among mar-
ried persons), and objective cognitive testing.
1.5.1. Biomarkers
Bodymass indexwas computed fromheight andweight. A
three-measurement seated resting blood pressure protocolwas
used. After a 5-minute period, readings 2 and 3 were collected
then averaged. Trained phlebotomists drew blood for the
following: a complete blood count, comprehensive chemistry
and lipid profiles, high sensitivity C-reactive protein (hsCRP),
and insulin. A BioPhotonic Scanner which shines a lightemittingdiode (LED) at a site on the palmwasused tomeasure
the carotenoid level, a clinical marker of phytonutrients
from vegetable consumption [29]. (http://www.nuskin.com/
en_BN/products/pharmanex/scanner.html).
1.5.2. Cognitive tests
Although we do not hypothesize cognitive performance
to change over the short duration of the study in a middle-
aged sample, we measured cognition (1-hour battery) at
baseline for covariation purposes, and tracked cognitive
performance over time to have the ability to demonstrate
stability (or to measure unintended positive or negative
changes, if they arise). Global cognitive ability was as-
sessed with the Montreal Cognitive Assessment [30],
episodic memory was assessed with the Rey Auditory Ver-
bal Learning Test [31], and verbal fluency was assessed
with the Controlled Oral Word Association Test [32].
Receptive vocabulary, working memory, processing speed,
and executive functioning were assessed using the tests
from the National Institutes of Health (NIH) Toolbox: Pic-
ture Vocabulary, Flanker Inhibitory Control and Attention
Test, List Sorting Working Memory Test, and Oral Symbol
Digit Test [33].
1.5.3. Surveys
Current depressive symptoms were measured with the
20-item Center for Epidemiologic Studies—Depression
scale [34]. Psychological stress was measured with the
10-item Perceived Stress Scale [35]. Sleep quality was
measured with the Pittsburgh Sleep Quality Index, con-
sisting of four questions concerning the amount of sleep
and 12 questions concerning sleep difficulties and treat-
ments [36]. Metacognitive concern was measured with a
set of seven items (each scored from 1 5 much better to
5 5 much worse), comparing current memory to how it
was 3 years ago, adapted from a questionnaire of func-
tional ability [37], with total score ranging from 7 to 35.
The seven items queried remembering: recent events,
names/faces of friends/relatives, train of thought, naviga-
tion to familiar places, operation of appliances, how to
perform household chores/hobbies, and an overall rating.
Intrinsic motivation was measured with the Situational
Intrinsic Motivational Scale subscale for intrinsic motiva-
tion [38]. This scale consists of four items enquiring as to
reasons the individual is engaged as a study participant
(each scored from 1 5 corresponds not at all to
7 5 corresponds exactly), with the total score ranging
from 4 to 28. Items included the following: because I
think that this activity is interesting, because I think that
this activity is pleasant, because this activity is fun, and
because I feel good when doing this activity. The Revised
University of Rhode Island Change Assessment produced
a readiness for change scale [39].
Dietary pattern was measured with the Diet History
Questionnaire, a 124-item food frequency questionnaire
developed and validated by the National Cancer Institute
Fig. 3. Average weekly number of app launches over first half of
intervention.
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diet accordance score was computed by summing across the
accordance of six food groups (fruits, vegetables, whole
grains, low-fat dairy, nuts/seeds/legumes, red/processed
meat) and two nutrients (sodium and added sugar) empha-
sized in the DASH diet, each with a score of 0 to 10, gener-
ating an overall DASH score ranging from 0 to 80.
To measure social engagement, four scales from the
NIH Toolbox were used: the Emotional Support Scale (range
8–40), the Friendship Scale (range 8–40), the Loneliness
Scale (range 5–25), and the Hostility Scale (range 8–40;
National Institutes of Health). Given that stronger marital re-
lationships predict better success at lifestyle change among
married persons, we measured couple satisfaction in our
married subsample using the 32-item Couple Satisfaction In-
dex [41]. Physical activity level was measured with two
questions, enquiring about vigorous and moderate physical
activity, in hours per week.2. Results
The Gray Matters sample is almost exclusively middle-
income and Caucasian, ranging in age from 40 to 64 years
(M 5 54.6; standard deviation [SD] 5 6.9), with two-
thirds of the sample female, and 77% college graduates.
Participants appear to be somewhat more at-risk than the
population generally, with 43.2% having a first-degree rela-
tive and 69.2% having a parent, grandparent, aunt, uncle, or
sibling with AD or other dementia. Motivational and readi-
ness for change characteristics suggested a highly motivated
group of participants, with nearly 40% having served in a
dementia care giving role.
Treatment group participants self-prioritized the six
behavioral domains, with overall rank order of importance
(from top to bottom priority): physical activity, cognitive
stimulation, healthy food choices, stress management,
sleep quality, and social engagement. A total of 73
(70%) of the 104 treatment group participants have at-
tended at least one “booster event,” with participation
ranging from 0 to 10 (M 5 2.0, SD 5 2.3) events over
the first 3 months of the intervention period. Most of
the treatment group participants having had at least two
email or text exchanges with their coaches over the initial
3 months of intervention.
Compliance with usage of the smartphone app was high,
with the number of app launches averaging approximately
300 launches per week, or about three/week/participant
(Fig. 3). Examples of average daily response to behavioral
questions on the app, plotted across the first 14 weeks of
the study, including within-person regression model statis-
tics, appear in Fig. 4. At study completion, daily behavioral
data will be condensed into weekly averages to study behav-
ioral trajectories over the 6-month intervention period for
inferential analyses.
Table 1 provides descriptive statistics on a wide range of
behavioral, biomarker, and sociodemographic variables,with a statistical test comparing treatment and control
groups at baseline. Control subjects were somewhat higher
in metacognitive concerns and total cholesterol than treat-
ment subjects, but the two groups did not differ on any other
measure.
Given the age of participants, clinical evaluations for de-
mentia will not be conducted. It is hypothesized that signif-
icantly greater gains in healthy lifestyle behaviors and both
subjective and objective outcomes will be observed in the
treatment group, compared with control group, over the 6-
month intervention period, when these data become avail-
able early in 2015. We did not assess side effects related to
exercise, such as muscle soreness, however, there were no
harms or unintended effects in either group reporting to per-
sonal coaches or study coordinators over the duration of the
study.3. Discussion
The Gray Matters proof-of-concept study uses a multido-
main healthy lifestyle intervention to promote positive
behavioral changes that are associated with lower AD risk,
with the goal to increase participants’ knowledge, intrinsic
motivation, and sense of empowerment to make such
changes.
The study, although large for a pilot, is revealing the types
of experiential activities that are most popular and effective,
and the extent to which participants are engaging in mean-
ingful and sustained behavioral change, at least in domains
they had initially prioritized. Over the first half of the inter-
vention period, participants exhibited a high adoption rate of
the smartphone app, with a promising trend toward increases
in the engagement of positive behaviors and reduction in
adverse self-reports (e.g. perceived stress) among treatment
group participants.
At study conclusion, treatment efficacy will be deter-
mined overall and by subgroups defined by baseline behav-
ioral and health characteristics, intrinsic motivation, and
engagement with intervention components. Focus groups
are planned after the post-test data collection, to gain
Fig. 4. Weekly averages of four daily behavioral levels (per smartphone application, averaging daily values within each week) for cognitively stimulating ac-
tivities (b 5 0.81, P 5 .001), social engagement (b 5 0.70, P 5 .008), perceived stress (b 5 20.81, P 5 .001), and physical activity (b 5 0.88, P , .001; all
coefficients are standardized).
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mine if engagement and behavioral change varied across
the course of the intervention. This pilot study has already
proven to be extremely informative in helping the research
team to fine-tune the intervention and plan additional inves-
tigations. Future studies will test for the efficacy of specific
intervention components. Although a maintenance phase
was originally planned, because of shortage of funding,
this is being removed from the study protocol. Future expan-
sion of the app will personalize various functions to incorpo-
rate each participant’s personal history, recent behavioral
gains/losses, health status, and predisposition to engage.
This stratified medicine approach may be the most powerful
to maximize the likelihood of success with individuals
across a wide range of readiness for change.
The racially and culturally homogeneous current sample
may limit the generalizability of study findings to other
groups. Nevertheless, contextual variables which might
otherwise confound results are generally absent and thus,
internal validity is increased. Future studies are planned
to test the efficacy of this intervention in a more ethnically
and socioeconomically diverse sample, mindful of the needfor cultural sensitivity. A question to be more fully ad-
dressed at this study’s conclusion is whether we can profile
and then target those participants who will engage, sustain,
and benefit from the intervention. We note that 43.2% of
the sample had a first degree relative with AD or other de-
mentia. Such individuals may be more highly motivated for
lifestyle changes because of perceived genetic risk for AD,
which may impact the generalizability of this pilot to a na-
tionally representative sample. Future research will
examine whether family history of AD predicts increased
behavioral change.
A cure for AD may still be years or even decades away,
and even when discovered may have contraindications for
universal application. Although genetics are largely non-
modifiable, interventions that assist individuals with mak-
ing and sustaining lifestyle behavioral changes that lower
AD risk are urgently needed as a complement to pharmaco-
logic therapies. Extensive research supports associations
between poorer lifestyle behaviors and cardiovascular
risk, and interventions to improve lifestyle behaviors have
shown promise. To date, research has established associa-
tions between poorer lifestyle behaviors and reduced
Table 1
Comparison of 104 treatment and 42 control group participants at pretest (t-test for independent groups with continuous variables, and chi-square test for
independence with categorical variables)
Continuous variables
Treatment group;
mean (SD)
Control group;
mean (SD)
t-test
(P-value)
Intrinsic motivation subscale of SIMS measure (range: 4–28) 16.6 (5.2) 15.0 (4.6) 21.596 (.11)
Metacognitive concerns (range: 7–35) 22.1 (2.7) 23.5 (2.1) 2.751 (.01)
Dietary approaches to stop Hypertension diet score (range: 0–80) 47.5 (7.0) 46.8 (7.3) 20.499 (.62)
Moderate intensity physical activity (minutes/week) 223.0 (222.8) 174.4 (148.6) 21.183 (.24)
Vigorous intensity physical activity (minutes/week) 103.5 (190.5) 94.4 (132.2) 20.259 (.80)
Body mass index 27.6 (5.2) 28.4 (5.1) 0.835 (.41)
Systolic blood pressure (mmHg) 115.9 (14.3) 116.4 (11.5) 0.210 (.83)
Diastolic blood pressure (mmHg) 74.4 (9.8) 74.8 (8.4) 0.207 (.84)
Pulse (beats/minute) 65.8 (9.3) 63.0 (9.8) 21.659 (.10)
Carotenoid palm scan (Raman counts) 34159 (11914) 35281 (13693) 0.493 (.62)
Age (yrs) 54.6 (6.7) 52.9 (7.3) 21.286 (.20)
Number of relatives with dementia 1.1 (1.0) 1.1 (1.0) 20.162 (.87)
Total cholesterol (mg/dL) 192.9 (32.9) 206.6 (36.2) 2.204 (.03)
C-reactive protein (mg/L) 2.4 (4.3) 3.1 (3.8) 0.888 (.38)
Triglycerides (mg/dL) 104.7 (54.3) 111.5 (49.2) 0.701 (.49)
Insulin (mIU/mL) 10.0 (9.3) 9.3 (6.5) 20.488 (.63)
Serum glucose (mg/dL) 92.5 (9.8) 95.5 (16.8) 1.358 (.18)
Categorical variables Treatment group,
N (%)
Control group,
N (%)
Chi-square
(P-value)
Gender
Male 36 (35.0%) 11 (31.4%) 0.144 (.70)
Female 67 (65.0%) 24 (68.8%)
Education
HS/GED 1 (1.0%) 1 (2.9%) 1.564 (.67)
College/trade 19 (18.6%) 4 (11.4%)
School/associate’s college
Graduate/bachelor’s 42 (41.2%) 16 (45.7%)
Graduate/professional degree 40 (39.2%) 14 (40.0%)
Overall health
Fair 8 (7.8%) 5 (14.3%) 1.397 (.50)
Good 60 (58.8%) 18 (51.4%)
Excellent 34 (33.3%) 12 (34.3%)
Abbreviations: SD, standard deviation; SIMS, Situational Intrinsic Motivational Scale; HS, high school; GED, general education development.
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we can determine whether lifestyle interventions such as
Gray Matters actually reduce AD risk, we need to under-
stand whether individuals will modify lifestyle behaviors
when presented with knowledge and resources concerning
the associations between these behaviors and AD risk.
Such is the purpose of the Gray Matters pilot intervention,
and preliminary data are promising. The delivery of these
interventions to middle-aged persons, decades before likely
disease onset, may alter cognitive health trajectories.
Building infrastructures for international collaborations,
as is occurring in Europe [42] will be necessary for address-
ing the projected AD incidence at a global level.Acknowledgments
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1. Systematic review: Published studies of randomized
controlled trials (RCT) of lifestyle interventions tar-
geting cognitive health were reviewed, along with
observational and RCT studies within specific behav-
ioral domains, to ascertain strength of association
with lowered Alzheimer’s disease (AD) risk.
2. Interpretation: This manuscript alerts the AD clinical
and research communities that this novel approach to
AD prevention, in the form of a lifestyle behavioral
intervention with custom smartphone application,
among middle-aged persons, is underway. To date,
preliminary behavioral change trajectories show
promising results.
3. Future directions: Six months hence, the results from
the treatment versus control group comparisons
examining change over the 6-month intervention
will become available. These results will clarify the
extent to which the intervention affects change in
biomarkers, body mass index, cognitive status, and
other outcomes. Additional RCT studies are planned
in more ethnically diverse samples, and to evaluate
whether positive effects are sustained over a subse-
quent 2-year maintenance phase.References
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